Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.
about
Role of factor H binding protein in Neisseria meningitidis virulence and its potential as a vaccine candidate to broadly protect against meningococcal diseaseMeningococcal serogroups A, C, W-135, and Y tetanus toxoid conjugate vaccine: a new conjugate vaccine against invasive meningococcal diseaseLong-term immunogenicity and safety after a single dose of the quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine in adolescents and adults: 5-year follow-up of an open, randomized trial.Antibody persistence up to 5 years after vaccination of toddlers and children between 12 months and 10 years of age with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine.Persistence of the immune response two years after vaccination with quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine (MenACWY-TT) in Asian adolescents.Antibody persistence up to 5 y after vaccination with a quadrivalent meningococcal ACWY-tetanus toxoid conjugate vaccine in adolescents.Immunogenicity and safety of a meningococcal serogroup A, C, Y and W glycoconjugate vaccine, ACWY-TT.Quadrivalent meningococcal serogroups A, C, W, and Y tetanus toxoid conjugate vaccine (MenACWY-TT): a review.Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.Meningococcal Quadrivalent Tetanus Toxoid Conjugate Vaccine (MenACWY-TT; Nimenrix®): A Review.
P2860
Q26995760-5E0D07B3-20E0-4D62-8183-8A0C0AACFE45Q27028161-1B82D105-F11C-4D3A-8DAB-2F8F5AB2876DQ35799561-0A4FC14B-266E-41EA-9EC8-D1CA01189C57Q37130274-054E1539-4035-4638-958C-780BA344B427Q37197065-76CDA86D-A80D-4369-AFCD-1FAE6DDAA358Q37713775-0790D387-6172-406F-BE7B-F1FD910B5CDCQ38109830-CCE916A8-9CBB-4E94-8991-6DB767DE857DQ38118371-1917DE20-E762-496F-BF75-4AD3E3C15813Q38743826-198ED6CD-D3F2-4245-89B6-D7EDC945BAA6Q47672096-F97289A3-B495-4C53-93BB-25A99221CE9A
P2860
Antibody persistence and immune memory 15 months after priming with an investigational tetravalent meningococcal tetanus toxoid conjugate vaccine (MenACWY-TT) in toddlers and young children.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Antibody persistence and immun ...... n toddlers and young children.
@ast
Antibody persistence and immun ...... n toddlers and young children.
@en
type
label
Antibody persistence and immun ...... n toddlers and young children.
@ast
Antibody persistence and immun ...... n toddlers and young children.
@en
prefLabel
Antibody persistence and immun ...... n toddlers and young children.
@ast
Antibody persistence and immun ...... n toddlers and young children.
@en
P2093
P2860
P356
P1476
Antibody persistence and immun ...... n toddlers and young children.
@en
P2093
Dominique Boutriau
Jacqueline M Miller
Markus Knuf
Veronique Bianco
Yaela Baine
P2860
P304
P356
10.4161/HV.20229
P577
2012-04-09T00:00:00Z